Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.

Nigolian H, Ribi C, Courvoisier DS, Pagano S, Alvarez M, Trendelenburg M, Huynh-Do U, Vuilleumier N, Dayer JM, Chizzolini C, Roux-Lombard P.

Rheumatology (Oxford). 2019 Aug 3. pii: kez306. doi: 10.1093/rheumatology/kez306. [Epub ahead of print]

PMID:
31377780
2.

All Ion Differential Analysis Refines the Detection of Terminal and Internal Diagnostic Fragment Ions for the Characterization of Biologics Product-Related Variants and Impurities by Middle-down Mass Spectrometry.

Griaud F, Denefeld B, Kao-Scharf CY, Dayer J, Lang M, Chen JY, Berg M.

Anal Chem. 2019 Jul 16;91(14):8845-8852. doi: 10.1021/acs.analchem.8b05886. Epub 2019 Jun 25.

PMID:
31187983
3.

Editorial: IL-1 Inhibition.

Oliviero F, Sfriso P, Punzi L, Dayer JM.

Front Pharmacol. 2019 Feb 12;10:87. doi: 10.3389/fphar.2019.00087. eCollection 2019. No abstract available.

4.
5.

A Brief History of IL-1 and IL-1 Ra in Rheumatology.

Dayer JM, Oliviero F, Punzi L.

Front Pharmacol. 2017 May 23;8:293. doi: 10.3389/fphar.2017.00293. eCollection 2017.

6.

A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.

Huttner A, Combescure C, Grillet S, Haks MC, Quinten E, Modoux C, Agnandji ST, Brosnahan J, Dayer JA, Harandi AM, Kaiser L, Medaglini D, Monath T; VEBCON and VSV-EBOVAC Consortia, Roux-Lombard P, Kremsner PG, Ottenhoff TH, Siegrist CA.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaaj1701. doi: 10.1126/scitranslmed.aaj1701. Erratum in: Sci Transl Med. 2019 Aug 21;11(506):.

7.

Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.

Dayer JA, Siegrist CA, Huttner A.

PLoS One. 2017 Mar 8;12(3):e0173148. doi: 10.1371/journal.pone.0173148. eCollection 2017.

8.

Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery.

Blanz J, Williams G, Dayer J, Délémonté T, Gertsch W, Ramstein P, Aichholz R, Trunzer M, Pearson D.

J Mass Spectrom. 2017 Apr;52(4):210-217. doi: 10.1002/jms.3918.

PMID:
28152561
9.

Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.

Croft AP, Naylor AJ, Marshall JL, Hardie DL, Zimmermann B, Turner J, Desanti G, Adams H, Yemm AI, Müller-Ladner U, Dayer JM, Neumann E, Filer A, Buckley CD.

Arthritis Res Ther. 2016 Nov 18;18(1):270.

10.

Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone.

Tiffany A, Vetter P, Mattia J, Dayer JA, Bartsch M, Kasztura M, Sterk E, Tijerino AM, Kaiser L, Ciglenecki I.

Clin Infect Dis. 2016 Jun 1;62(11):1360-1366. doi: 10.1093/cid/ciw158. Epub 2016 Mar 21.

11.

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.

Corbera-Bellalta M, Planas-Rigol E, Lozano E, Terrades-García N, Alba MA, Prieto-González S, García-Martínez A, Albero R, Enjuanes A, Espígol-Frigolé G, Hernández-Rodríguez J, Roux-Lombard P, Ferlin WG, Dayer JM, Kosco-Vilbois MH, Cid MC.

Ann Rheum Dis. 2016 Jun;75(6):1177-86. doi: 10.1136/annrheumdis-2015-208371. Epub 2015 Dec 23.

12.

Interleukin-1 function and role in rheumatic disease.

Schett G, Dayer JM, Manger B.

Nat Rev Rheumatol. 2016 Jan;12(1):14-24. doi: 10.1038/nrrheum.2016.166. Epub 2015 Dec 10. Review.

PMID:
26656658
13.

Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Felicetti M, Frallonardo P, Facco M, Boso D, Molena B, Zambello R, Ramonda R, Cozzi F, Scarpa R, Basso G, Semenzato G, Dayer JM, Doria A, Punzi L.

J Rheumatol Suppl. 2015 Nov;93:48-52. doi: 10.3899/jrheum.150636.

PMID:
26523057
14.

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.

Huttner A, Dayer JA, Yerly S, Combescure C, Auderset F, Desmeules J, Eickmann M, Finckh A, Goncalves AR, Hooper JW, Kaya G, Krähling V, Kwilas S, Lemaître B, Matthey A, Silvera P, Becker S, Fast PE, Moorthy V, Kieny MP, Kaiser L, Siegrist CA; VSV-Ebola Consortium.

Lancet Infect Dis. 2015 Oct;15(10):1156-1166. doi: 10.1016/S1473-3099(15)00154-1. Epub 2015 Aug 4.

15.

Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report.

Schibler M, Vetter P, Cherpillod P, Petty TJ, Cordey S, Vieille G, Yerly S, Siegrist CA, Samii K, Dayer JA, Docquier M, Zdobnov EM, Simpson AJH, Rees PSC, Sarria FB, Gasche Y, Chappuis F, Iten A, Pittet D, Pugin J, Kaiser L.

Lancet Infect Dis. 2015 Sep;15(9):1034-1040. doi: 10.1016/S1473-3099(15)00229-7. Epub 2015 Jul 19.

PMID:
26201298
16.

Transcriptional network profile on synovial fluid T cells in psoriatic arthritis.

Fiocco U, Martini V, Accordi B, Caso F, Costa L, Oliviero F, Scanu A, Facco M, Boso D, Gatto M, Felicetti M, Frallonardo P, Ramonda R, Piva L, Zambello R, Agostini C, Scarpa R, Basso G, Semenzato G, Dayer JM, Punzi L, Doria A.

Clin Rheumatol. 2015 Sep;34(9):1571-80. doi: 10.1007/s10067-015-3002-2. Epub 2015 Jul 9.

PMID:
26152611
17.

[Ebola: the unexpected emerging disease].

Vetter P, Schibler M, Dayer JA, Kaiser L.

Rev Med Suisse. 2015 Apr 15;11(470):877-83. Review. French.

PMID:
26050306
18.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaître B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmüller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA.

N Engl J Med. 2016 Apr 28;374(17):1647-60. doi: 10.1056/NEJMoa1502924. Epub 2015 Apr 1.

19.

Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine.

Blanz J, Délémonté T, Pearson D, Luneau A, Ritzau M, Gertsch W, Ramstein P, Dayer J, Desrayaud S, Braun E, Aichholz R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 May 1;989:1-10. doi: 10.1016/j.jchromb.2015.02.044. Epub 2015 Mar 10.

PMID:
25797717
20.

IL-1ß and IL-8 are scavenged by the hexadecylamide derivative of hyaluronic acid: a new mechanism.

Oliviero F, Scanu A, Ramonda R, Frallonardo P, Sfriso P, Dayer JM, Punzi L.

J Biomed Mater Res A. 2015 Sep;103(9):2823-9. doi: 10.1002/jbm.a.35422. Epub 2015 Feb 26.

PMID:
25689957
21.

Tribute to Stephen M. Krane.

Dayer JM, Goldring MB, Goldring SR, Kronenberg HM, Martin TJ, Russell RG.

J Bone Miner Res. 2015 May;30(5):751-2. doi: 10.1002/jbmr.2477. No abstract available.

22.

The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study.

Pisetsky DS, Trace SE, Brownley KA, Hamer RM, Zucker NL, Roux-Lombard P, Dayer JM, Bulik CM.

Cytokine. 2014 Sep;69(1):110-5. doi: 10.1016/j.cyto.2014.05.018. Epub 2014 Jun 14.

23.

A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.

Mero A, Campisi M, Favero M, Barbera C, Secchieri C, Dayer JM, Goldring MB, Goldring SR, Pasut G.

J Control Release. 2014 Aug 10;187:30-8. doi: 10.1016/j.jconrel.2014.05.008. Epub 2014 May 15.

PMID:
24837189
24.

JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis.

Fiocco U, Accordi B, Martini V, Oliviero F, Facco M, Cabrelle A, Piva L, Molena B, Caso F, Costa L, Scanu A, Pagnin E, Atteno M, Scarpa R, Basso G, Semenzato G, Punzi L, Doria A, Dayer JM.

Immunol Res. 2014 Jan;58(1):61-9. doi: 10.1007/s12026-013-8481-0.

PMID:
24385089
25.

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy.

Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF.

Nat Med. 2013 Jul;19(7):822-4. doi: 10.1038/nm.3260. Review. No abstract available.

PMID:
23836224
26.

Pro- or anti-inflammatory role of apolipoprotein A-1 in high-density lipoproteins?

Vuilleumier N, Dayer JM, von Eckardstein A, Roux-Lombard P.

Swiss Med Wkly. 2013 May 25;143:w13781. doi: 10.4414/smw.2013.13781. eCollection 2013. Review.

27.

Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.

Corbera-Bellalta M, García-Martínez A, Lozano E, Planas-Rigol E, Tavera-Bahillo I, Alba MA, Prieto-González S, Butjosa M, Espígol-Frigolé G, Hernández-Rodríguez J, Fernández PL, Roux-Lombard P, Dayer JM, Rahman MU, Cid MC.

Ann Rheum Dis. 2014 Mar;73(3):616-23. doi: 10.1136/annrheumdis-2012-202883. Epub 2013 Apr 27.

PMID:
23625984
28.

Introduction to "Synovitis--an inflammation of joints destroying the bone".

Pitzalis C, Veale D, Dayer JM.

Swiss Med Wkly. 2012 Oct 15;142:w13712. doi: 10.4414/smw.2012.13712. eCollection 2012. No abstract available.

29.

Response to 'Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4'.

Oliviero F, Scanu A, Dayer JM, Fiocco U, Sfriso P, Punzi L.

Arthritis Res Ther. 2012 Sep 12;14(5):405; author reply 406. doi: 10.1186/ar3863. No abstract available.

30.

Autoinflammatory diseases: how to put the fire inside the body out?

Doria A, Dayer JM, Punzi L.

Autoimmun Rev. 2012 Nov;12(1):1-4. doi: 10.1016/j.autrev.2012.07.013. Epub 2012 Aug 2.

PMID:
22884550
31.

Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers.

Fiocco U, Sfriso P, Oliviero F, Lunardi F, Calabrese F, Scagliori E, Cozzi L, Di Maggio A, Nardacchione R, Molena B, Felicetti M, Gazzola K, Stramare R, Rubaltelli L, Accordi B, Costa L, Roux-Lombard P, Punzi L, Dayer JM.

Joint Bone Spine. 2013 Mar;80(2):165-70. doi: 10.1016/j.jbspin.2012.06.016. Epub 2012 Aug 3.

PMID:
22867975
32.

Synovial biomarkers in psoriatic arthritis.

Fiocco U, Oliviero F, Sfriso P, Calabrese F, Lunardi F, Scagliori E, Rubaltelli L, Stramare R, Di Maggio A, Nardacchione R, Cozzi L, Molena B, Felicetti M, Gazzola K, Lo Nigro A, Accordi B, Roux-Lombard P, Dayer JM, Punzi L.

J Rheumatol Suppl. 2012 Jul;89:61-4. doi: 10.3899/jrheum.120246.

PMID:
22751595
33.

Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes.

Ferrari-Lacraz S, Sebbag M, Chicheportiche R, Foulquier C, Serre G, Dayer JM.

Eur Cytokine Netw. 2012 Jun;23(2):36-44. doi: 10.1684/ecn.2012.0303.

34.

Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.

Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, Saraux A, Roux-Lombard P, Mariette X.

Ann Rheum Dis. 2012 Jul;71(7):1243-8. doi: 10.1136/annrheumdis-2011-200975. Epub 2012 Apr 24.

PMID:
22532637
35.

Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase.

Scanu A, Oliviero F, Ramonda R, Frallonardo P, Dayer JM, Punzi L.

Ann Rheum Dis. 2012 Apr;71(4):621-4. doi: 10.1136/annrheumdis-2011-200711. Epub 2012 Jan 30.

PMID:
22294622
36.

Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

Bijl M, Agmon-Levin N, Dayer JM, Israeli E, Gatto M, Shoenfeld Y.

Autoimmun Rev. 2012 Jun;11(8):572-6. doi: 10.1016/j.autrev.2011.10.015. Epub 2011 Oct 22. Review.

PMID:
22037116
37.

[HDL inhibit cytokine production in a mouse model of urate crystal-induced inflammation].

Scanu A, Oliviero F, Luisetto R, Sfriso P, Dayer JM, Burger D, Punzi L.

Reumatismo. 2010 Oct-Dec;62(4):266-72. Italian.

38.

Interleukin-6: from identification of the cytokine to development of targeted treatments.

Assier E, Boissier MC, Dayer JM.

Joint Bone Spine. 2010 Dec;77(6):532-6. doi: 10.1016/j.jbspin.2010.07.007. Epub 2010 Sep 24. Review.

PMID:
20869898
39.

Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.

Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, Saurat JH, Roosnek E, Chizzolini C.

Eur J Immunol. 2010 Sep;40(9):2450-9. doi: 10.1002/eji.201040461.

40.

Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint.

Fiocco U, Sfriso P, Oliviero F, Roux-Lombard P, Scagliori E, Cozzi L, Lunardi F, Calabrese F, Vezzù M, Dainese S, Molena B, Scanu A, Nardacchione R, Rubaltelli L, Dayer JM, Punzi L.

Arthritis Res Ther. 2010;12(4):R148. doi: 10.1186/ar3090. Epub 2010 Jul 19.

41.

Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L.

Autoimmun Rev. 2010 Sep;9(11):780-4. doi: 10.1016/j.autrev.2010.07.001. Epub 2010 Jul 8. Review.

PMID:
20620241
42.

Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.

Gruaz L, Delucinge-Vivier C, Descombes P, Dayer JM, Burger D.

PLoS One. 2010 Feb 25;5(2):e9418. doi: 10.1371/journal.pone.0009418.

43.

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Dayer JM, Choy E.

Rheumatology (Oxford). 2010 Jan;49(1):15-24. doi: 10.1093/rheumatology/kep329. Epub 2009 Oct 23. Review.

44.

Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Chizzolini C, Dayer JM, Miossec P.

Arthritis Res Ther. 2009;11(5):246. doi: 10.1186/ar2767. Epub 2009 Oct 14. Review.

45.

Synovial tissue rank ligand expression and radiographic progression in rheumatoid arthritis: observations from a proof-of-concept randomized clinical trial of cytokine blockade.

Rooney T, Edwards CK 3rd, Gogarty M, Greenan L, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B.

Rheumatol Int. 2010 Nov;30(12):1571-80. doi: 10.1007/s00296-009-1191-1. Epub 2009 Oct 22.

PMID:
19847430
46.

Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade.

Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B.

Ann Rheum Dis. 2010 Apr;69(4):706-14. doi: 10.1136/ard.2009.108324. Epub 2009 May 20.

PMID:
19460761
47.

Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

Oliviero F, Sfriso P, Baldo G, Dayer JM, Giunco S, Scanu A, Bernardi D, Ramonda R, Plebani M, Punzi L.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1):79-83.

PMID:
19327233
48.

Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.

Maurer-Cecchini A, Decuypere S, Chappuis F, Alexandrenne C, De Doncker S, Boelaert M, Dujardin JC, Loutan L, Dayer JM, Tulliano G, Arevalo J, Llanos-Cuentas A, Chizzolini C.

Infect Immun. 2009 May;77(5):2022-9. doi: 10.1128/IAI.01513-08. Epub 2009 Feb 23.

49.

European consensus statement on the terminology used in the management of lupus glomerulonephritis.

Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A, Vasconcelos C, Hughes G.

Lupus. 2009 Mar;18(3):257-63. doi: 10.1177/0961203308100481.

PMID:
19213865
50.

Serum levels of tissue inhibitor of metalloproteinase-1 and periarticular bone loss in early rheumatoid arthritis.

Murphy E, Roux-Lombard P, Rooney T, Fitzgerald O, Dayer JM, Bresnihan B.

Clin Rheumatol. 2009 Mar;28(3):285-91. doi: 10.1007/s10067-008-1037-3. Epub 2008 Nov 26.

PMID:
19050823

Supplemental Content

Support Center